The first cluster randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

L Natoli; J Ward; B Hengel; L M Causer; S Badman; A Tangey; S N Tabrizi; D Whiley; B Donovan; C Fairley

doi:10.1136/sextrans-2013-051184.1080

The first cluster randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

L Natoli, J Ward, B Hengel, L M Causer, S Badman, A Tangey, S N Tabrizi, D Whiley, B Donovan, C Fairley

Research output: Contribution to conference › Poster

Abstract

Introduction In many settings, control of sexually transmissible infections (STIs) is compromised by lack of laboratory infrastructure, physical distance from laboratories and loss to follow up of patients. Point-of-care (POC) tests have the potential to provide timely diagnosis, treatment and partner notification, and in turn reduce infection rates. In April 2013, we will implement the first cluster randomised trial of chlamydia and gonorrhoea POC testing in remote Aboriginal communities where STIs are endemic.

Original language	English
Pages	A345
Number of pages	1
DOIs	https://doi.org/10.1136/sextrans-2013-051184.1080
Publication status	Published - 14 Jul 2013
Externally published	Yes
Event	STI & AIDS World Congress 2013 : Threatening past, promising future - Vienna, Austria Duration: 14 Jul 2013 → 17 Jul 2013

Conference

Conference	STI & AIDS World Congress 2013
Country/Territory	Austria
City	Vienna
Period	14/07/13 → 17/07/13

Keywords

Chlamydia
Gonorrhoea
Point-of-Care

Access to Document

10.1136/sextrans-2013-051184.1080Licence: In Copyright

Cite this

@conference{479606c4b2314105b6265d5a25417a03,

title = "The first cluster randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay",

abstract = "Introduction In many settings, control of sexually transmissible infections (STIs) is compromised by lack of laboratory infrastructure, physical distance from laboratories and loss to follow up of patients. Point-of-care (POC) tests have the potential to provide timely diagnosis, treatment and partner notification, and in turn reduce infection rates. In April 2013, we will implement the first cluster randomised trial of chlamydia and gonorrhoea POC testing in remote Aboriginal communities where STIs are endemic.",

keywords = "Chlamydia, Gonorrhoea, Point-of-Care",

author = "L Natoli and J Ward and B Hengel and Causer, {L M} and S Badman and A Tangey and Tabrizi, {S N} and D Whiley and B Donovan and C Fairley",

year = "2013",

month = jul,

day = "14",

doi = "10.1136/sextrans-2013-051184.1080",

language = "English",

pages = "A345",

note = "STI & AIDS World Congress 2013 : Threatening past, promising future ; Conference date: 14-07-2013 Through 17-07-2013",

}

TY - CONF

T1 - The first cluster randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

AU - Natoli, L

AU - Ward, J

AU - Hengel, B

AU - Causer, L M

AU - Badman, S

AU - Tangey, A

AU - Tabrizi, S N

AU - Whiley, D

AU - Donovan, B

AU - Fairley, C

PY - 2013/7/14

Y1 - 2013/7/14

N2 - Introduction In many settings, control of sexually transmissible infections (STIs) is compromised by lack of laboratory infrastructure, physical distance from laboratories and loss to follow up of patients. Point-of-care (POC) tests have the potential to provide timely diagnosis, treatment and partner notification, and in turn reduce infection rates. In April 2013, we will implement the first cluster randomised trial of chlamydia and gonorrhoea POC testing in remote Aboriginal communities where STIs are endemic.

AB - Introduction In many settings, control of sexually transmissible infections (STIs) is compromised by lack of laboratory infrastructure, physical distance from laboratories and loss to follow up of patients. Point-of-care (POC) tests have the potential to provide timely diagnosis, treatment and partner notification, and in turn reduce infection rates. In April 2013, we will implement the first cluster randomised trial of chlamydia and gonorrhoea POC testing in remote Aboriginal communities where STIs are endemic.

KW - Chlamydia

KW - Gonorrhoea

KW - Point-of-Care

U2 - 10.1136/sextrans-2013-051184.1080

DO - 10.1136/sextrans-2013-051184.1080

M3 - Poster

SP - A345

T2 - STI & AIDS World Congress 2013

Y2 - 14 July 2013 through 17 July 2013

ER -

The first cluster randomised trial of a molecular chlamydia and gonorrhoea point-of-care assay

Abstract

Conference

Keywords

Access to Document

Fingerprint

Cite this